Early activation of peripheral monocytes with hallmarks of M1 and M2 monocytic cells in excessive alcohol drinkers: a pilot study by Walline, Crystal C. et al.
Early activation of peripheral monocytes with hallmarks of M1 
and M2 monocytic cells in excessive alcohol drinkers: a pilot 
study
Crystal C Walline1, Janice S Blum2, Tobyn Linton3, Darrin Mangiacarne3, and Suthat 
Liangpunsakul4,5,6
1Department of Biology, University of North Carolina, Pembroke, North Carolina, USA
2Department of Microbiology and Immunology, Indiana University School of Medicine, 
Indianapolis, Indiana, USA
3Fairbanks Drug and Alcohol Rehabilitation, Indianapolis, Indiana, USA
4Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School 
of Medicine, Indianapolis, Indiana, USA
5Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA
6Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 
Indianapolis, Indiana, USA
Abstract
Excessive drinking can lead to the development of immune dysfunction. Our aim is to investigate 
the effect of alcohol on immune activation from circulating peripheral blood monocytes in 
excessive drinkers (EDs). Twenty-two EDs and healthy controls were enrolled. Time line follow-
back was used to quantify the amount of alcohol consumed in the past 30 days before enrollment. 
Peripheral blood-derived CD14+ monocytes were isolated for gene expression analyses. Serum 
interleukin (IL)-6, IL-10 and lipopolysaccharides (LPS) were also measured. We found that serum 
LPS concentrations were significantly higher in EDs compared with controls (P<0.05). While no 
differences in the levels of circulating IL-6 and IL-10 were observed, the relative levels of gene 
transcripts (RQ) for Il6 (an M1-polarizing cytokine) and Il10 (an M2-polarizing cytokine) were 
significantly higher in peripheral blood-derived monocytes from EDs compared with controls (Il6: 
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P<0.01. Il10: P<0.05). EDs exhibit early immune activation of peripheral blood monocyte mRNA 
transcripts, notably Il6 and Il10. Future studies are needed to explore the clinical implications of 
our findings and determine whether the levels of Il6 and Il10 mRNA expression can be used to 
identify those with excessive drinking and to monitor for alcohol abstinence.
INTRODUCTION
Endotoxin (or lipopolysaccharides (LPS)) is an important factor driving the pathogenesis of 
alcohol-induced liver injury.1–3 The changes in innate and adaptive immunity in response to 
LPS can have a profound effect on the severity and progression of alcoholic liver disease 
(ALD).2 Serum levels of pro-inflammatory cytokines interleukin-1α (IL-1α), IL-1β, IL-6 
and tumor necrosis factor alpha (TNFα) increase in patients with ALD, and elevated IL-6 is 
correlated with increased mortality.45 This pilot study was designed to investigate if changes 
in innate immune activation could be detected in patients with excessive alcohol use 
compared with healthy controls. The plasma levels of IL-6 and IL-10 in these subjects were 
normal, despite having elevated serum LPS levels. However, early signs of innate immune 
cell activation were detectable in peripheral blood monocytes as evidenced by increased Il6 
and Il10 gene expression. These data indicate evaluating a limited number of gene 
transcripts as a measure of monocyte activation could be of use to detect early immune 
system dysfunction in patients with excessive alcohol use.
MATERIALS AND METHODS
Human subject recruitment
Twenty-two excessive drinkers (EDs) who were seen at the Fairbanks Drug and Alcohol 
Treatment Center (Indianapolis, Indiana, USA) were enrolled. All met the criteria for 
‘excessive drinking’ according to the National Institute of Health/National Institute on 
Alcohol Abuse and Alcoholism; which are defined as men who drink >4 standard drinks in a 
day (or >14 per week) and women who drink >3 standard drinks in a day (or >7 per week).6 
Twenty non-EDs (healthy controls) without known medical or surgical histories were 
recruited from Richard L. Roudebush Veterans Administration Medical Center in 
Indianapolis, Indiana. All participants were at least 21 years of age and provided informed 
consent.
Endotoxin assay
The Endpoint Chromogenic Limulus Amebocyte Lysate test was used to detect LPS 
endotoxin (Lonza, Allendale, New Jersey, USA).
Analysis for plasma IL-6 and IL-10
ELISAs were performed using Costar EIA/RIA flat-bottomed 96-well plates coated over 
night with capture antibody diluted in 0.1 M carbonate buffer, pH 9.5. For the remaining 
steps, all antibodies and human plasma were diluted in phosphate buffered saline (PBS)/1 
per cent bovine serum albumin. IL-6 and IL-10 were measured in plasma using a standard 
ELISA with 2 μg/mL purified and 1 μg/mL biotinylated antibodies (BD Biosciences, San 
Jose, California, USA) and streptavidin-horseradish peroxidase (Thermo Fisher Scientific).
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Quantitative real-time PCR (qRT-PCR)
Blood was collected in tubes containing sodium heparin (Becton Dickinson), rested 
overnight at 22–25°C, and centrifuged at 2000 rpm for 10 min at 22°C; plasma was removed 
and stored at −80°C until use. One part blood was diluted with one part room temperature 
PBS. One part Ficoll-Hypaque was layered underneath the blood/PBS mixture and 
centrifuged at 1600 rpm for 30 min at 22°C. The polymorphonuclear cell (PMN) layer was 
removed, washed two times with 4°C PBS and counted. Typical recovery was 1 to 3×106 
PMNs per milliliter blood, and viability was determined by the Trypan blue exclusion 
method and was generally >95 per cent. Cells were separated into CD14+ mononuclear and 
CD14− non-mononu-clear fractions using the Human Pan Monocyte Isolation Kit (Miltenyi 
Biotec, Auburn, California, USA). Cells were flash frozen and stored at −80°C until use. 
Total RNA was extracted (RNeasy Mini kit, Qiagen, Valencia, California, USA) and cDNA 
was generated using the High-Capacity cDNA Reverse Transcription Kit; qRT-PCR was 
performed using commercially available TaqMan primers and the ABI Prism 7500 Fast RT-
PCR System (Applied Biosystems, Carlsbad, California, USA). Gene expression was 
quantitated relative to beta-2 microglobulin mRNA levels and presented as an arbitrary fold 
change compared with control samples.
Statistical analyses
Statistical significance was determined using the non-parametric Mann-Whitney test with a 
confidence level of 95 per cent (GraphPad Prism V.6.02). *P<0.05; **P<0.01.
RESULTS
Study cohort characteristics
The clinical characteristics of the study patients are shown in table 1. As expected, EDs had 
significantly higher Alcohol Use Disorders Identification Test (AUDIT) scores (27.4±8.1 vs 
3.3±3.1, P<0.001) and higher alcohol consumption over the last 30 days (242.5±130 vs 
9.9±15.1 standard drinks, P<0.001) compared with controls. There was no significant 
difference in the levels of gamma-glutamyl transpeptidase (GGT), aspartate 
aminotransferase (AST) or alanine amino-transferase (ALT) levels between groups. EDs had 
higher levels of serum carbohydrate deficient transferrin (CDT)(3.0±0.8 vs 1.6±0.5, 
P=0.02).
Levels of LPS, IL-6 and IL-10 in EDs and controls
The levels of serum LPS in EDs were significantly higher than those in controls (0.26±0.07 
vs 0.13±0.03 EU/mL, P<0.05). We next measured the LPS-induced production of cytokines, 
including IL-6 and IL-10. Interestingly, despite the increase in serum LPS in EDs, we did 
not observe a difference in the plasma levels of IL-6 (470±484 vs 615±742 pg/mL, in 
controls and EDs, respectively, P>0.05) and IL-10 (254±172 vs EDs: 365±484 pg/mL, 
P>0.05) between these two groups.
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Early activations of innate immune response in EDs and controls
To determine if early activation of the innate immune system could be detected in EDs due 
to the increase in the levels of serum LPS, we measured the relative expression of mRNAs 
for monocyte differentiation markers and cytokines in peripheral blood-derived CD14+ 
monocytes using qRT-PCR. While we did not observe a difference in the plasma levels of 
IL-6 and IL-10, we found that Il6 (associated with M1-polarization) and Il10 (associated 
with M2-polarization) gene transcripts were significantly increased in EDs compared with 
controls (figure 1A,B). However, we did not find a difference in transcript levels for other 
M1 monocyte differentiation markers (Il1b, Tnf and Ccl2) and membrane protein markers of 
the M2 phenotype (mannose receptor (Mrc1)) (figure 1C–1F). Lastly, despite increased 
serum LPS, EDs did not have the alteration in the gene expression of toll-like receptor 4, the 
binding target of LPS (figure 1G). These results indicate that excessive alcohol consumption 
leads to an early activation of peripheral monocytes with increased transcription of a limited 
subset of hallmark cytokines Il6 and Il10.
DISCUSSION
Circulating monocytes and macrophages are acutely sensitive to changes in metabolites and 
nutrients, inflammatory stimuli and tissue damage.7 We recently reported an increase in the 
levels of LPS and markers of monocyte activations, notably soluble CD14 and soluble 
CD163 among EDs.3 At the cellular levels, a subset of circulating monocytes and 
macrophages has been identified and distinguished based on transcriptional profiles, cell 
surface marker expression and functions, such as cytokine and chemokine release.78 At the 
extremes are dedicated M1 cells associated with the production of pro-inflammatory 
cytokines (eg, IL-6) and pathogen clearance.9 Conversely, M2 cells mediate immune 
suppression and tissue remodeling/regeneration.9 Il10 gene expression is associated with M2 
cells depending on the context of co-expressed signaling molecules.8 Changes in serum IL-6 
and IL-10 production from activated, circulating monocytes/macrophages are observed in 
several inflammatory disorders including multiple sclerosis, type 1 and type 2 diabetes, 
metabolic syndrome, obesity, non-alcoholic fatty liver disease and ALD.10–14
In EDs, CD14+ peripheral blood monocytes displayed a significant increase in Il6 and Il10 
transcripts. We did not distinguish whether this reflects the presence of multiple distinct 
monocyte subsets or a continuum of circulating monocytic cells. However, Kupffer cells, the 
resident liver macrophages, produce both IL-6 and IL-10 as an innate immune response to 
liver damage.1516 LPS stimulation of Kupffer cells induces IL-6 production which 
transiently activates STAT3, leading to the production of pro-inflammatory cytokines.2 In 
contrast, IL-6 can also activate hepatocytes, hepatic stellate cells and sinusoidal endothelial 
cells which result in downstream signaling that protects against liver injury, promotes liver 
regeneration and regulates liver fibrosis and inflammation.17–19 IL-10 causes a prolonged 
activation of STAT3 in Kupffer cells, leading to an anti-inflammatory response by 
attenuating LPS, TNFα and complement activation, resulting in dampened liver 
inflammation.217 The interplay of IL-6 and IL-10 in liver inflammation and disease has been 
demonstrated in animal studies.2021 Although IL-10 is associated with anti-inflammatory 
effects, the immune suppressing effects of prolonged IL-10 production may enhance the 
Walline et al. Page 4
J Investig Med. Author manuscript; available in PMC 2019 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
susceptibility of heavy drinkers to viruses such as hepatitis B or HIV, as IL-10 appears to 
favor virus infection and persistence.2223
The strengths of this study are the prospective design and the well-characterized cohort of 
EDs. However, our pilot study consisted of a small sample size. Future studies in a larger 
cohort are needed to confirm our observation. In addition, a recent study demonstrated that 
the increase in immune/inflammatory changes in response to the LPS is more prominent in 
female drinkers.24 The study design to explore the gender differences in the expression of 
the gene transcript on peripheral blood mononuclear cells in responses to alcohol is 
warranted.
In summary, our pilot study suggested that the changes in the Il6 and Il10 transcripts (in the 
absence of elevated plasma/serum cytokines) may be an early indicator of metabolic change 
associated with excessive alcohol consumption. Future studies are needed to explore the 
clinical implications of our findings and determine whether the levels of Il6 and Il10 mRNA 
expression can be used to identify those with excessive drinking and to monitor for alcohol 
abstinence.
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Figure 1. 
Excessive alcohol drinking induces increased expression of Il6 and Il10 gene transcripts in 
peripheral blood monocytes. CD14+ monocytes were separated from other 
polymorphonuclear cell with the Human Pan Monocyte Isolation Kit. Total RNA from 
CD14+ monocytes was reverse transcribed and analyzed by qRT-PCR for expression of 
monocyte/macrophage differentiation markers. The relative expression of Il6 and Il10 gene 
transcripts were significantly increased in the excessive drinkers (ED) compared with 
controls (C) (Il6, **P<0.01; Il10, *P<0.05). RQ, Relative quantification.
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Table 1
Selected demographic, clinical and laboratory characteristics of the study cohort
Health controls (N = 20) Excessive drinkers (N=22) P values
Age (years) 30.7±9.1 36.9±10.0 0.05
Males (N, %) 17 (85) 15 (69) 0.18
Race (Caucasian, N, %) 13 (65) 17 (77) 0.62
Smoking (N, %) 14 (70) 15 (68) 1.00
Height (cm) 178.5±7.7 172.9±8.1 0.06
Weight (kg) 78.2±8.7 77.5±9.8 0.39
BMI (kg/m2) 29.1±5.3 26.1±3.5 0.09
Waist circumference (cm) 103.1±15.9 93.1±10.0 0.06
AUDIT-C scores 3.3±3.1 27.4±8.1 <0.001
Total standard drinks last 30 days 9.9±15.1 242.5±130.0 <0.001
AST (U/L) 31.1±17.3 23.5±7.1 0.15
ALT (U/L) 22.2±16.5 25.2±11.5 0.26
Albumin (g/dL) 4.1±0.2 3.7±0.4 0.03
Total protein (g/dL) 7.8±0.6 6.4±0.6 <0.01
GGT (U/L) 29.0±13.4 32.3±24.1 0.63
% CDT 1.6±0.5 3.0±0.8 0.02
Serum LPS (EU/mL) 0.13±0.03 0.26±0.07 <0.05
Plasma IL-6 (pg/mL) 470±484 615±742 0.09
Plasma IL-10 (pg/mL) 254±172 365±484 0.10
ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUDIT-C, Alcohol Use Disorders Identification Test; BMI, body mass index; 
CDT, carbohydrate-deficient transferrin; GGT, gamma-glutamyl transpeptidase; IL, interleukin; LPS, lipopolysaccharides.
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